Clinical Trial Update: Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating the combination of regorafenib and pembrolizumab in adults with advanced or metastatic colorectal cancer, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Regorafenib (regorafenib)

Snippet

Sponsor: University of Southern California | Conditions: Colorectal Cancer, Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING